Entropy Neurodynamics Limited

As of June 30, 2025, Entropy Neurodynamics Limited carries a market capitalization of 43.17M, placing it among publicly traded companies globally. Its enterprise value stands at 40.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2025, Entropy Neurodynamics Limited has 1.44B shares outstanding.

These figures are as of June 30, 2025.

As of June 30, 2025, Entropy Neurodynamics Limited maintains a current ratio of 9.08, meaning it holds 9.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2025, Entropy Neurodynamics Limited posted a negative return on equity (ROE) of -105.69, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -85.02, reflecting losses generated across the asset base.

As of the close on October 22, 2026, Entropy Neurodynamics Limited's stock has declined approximately 13.51% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.03.

These figures cover the twelve months ended June 30, 2025. EBITDA reached -6.81M, while operating income came in at -6.73M.

These figures are as of June 30, 2025. Total book value stands at 5.96M, with working capital of 5.65M providing operational flexibility.

These figures cover the twelve months ended June 30, 2025.

These figures cover the twelve months ended June 30, 2025. Total shareholder yield is negative at -12.96, meaning Entropy Neurodynamics Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Entropy Neurodynamics Limited's most recent stock split took place on April 15, 2024 with a 5:2 split ratio.